DSGN icon

Design Therapeutics
DSGN

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$15
60% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Oppenheimer
Oppenheimer
Trevor Allred
100% 1-yr DSGN win rate
7 Jan ‘26 8 days ago
Leerink Partners
Leerink Partners
Joseph Schwartz
100% 1-yr DSGN win rate
3 Dec ‘25 1 month ago
RBC Capital
RBC Capital
Leonid Timashev
100% 1-yr DSGN win rate
20 Nov ‘25 1 month ago